SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-066909
Filing Date
2021-05-14
Accepted
2021-05-14 16:32:17
Documents
63
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2111798d1_10q.htm 10-Q 700729
2 EXHIBIT 31.1 tm2111798d1_ex31-1.htm EX-31.1 9242
3 EXHIBIT 31.2 tm2111798d1_ex31-2.htm EX-31.2 8975
4 EXHIBIT 32.1 tm2111798d1_ex32-1.htm EX-32.1 5092
5 EXHIBIT 32.2 tm2111798d1_ex32-2.htm EX-32.2 5265
  Complete submission text file 0001104659-21-066909.txt   4734972

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nnvc-20210331.xml EX-101.INS 1058682
7 XBRL TAXONOMY EXTENSION SCHEMA nnvc-20210331.xsd EX-101.SCH 49531
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nnvc-20210331_cal.xml EX-101.CAL 41399
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nnvc-20210331_def.xml EX-101.DEF 185897
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nnvc-20210331_lab.xml EX-101.LAB 320727
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nnvc-20210331_pre.xml EX-101.PRE 312954
Mailing Address 1 CONTROLS DRIVE SHELTON CT 06484
Business Address 1 CONTROLS DRIVE SHELTON CT 06484 (203) 937-6137
NANOVIRICIDES, INC. (Filer) CIK: 0001379006 (see all company filings)

IRS No.: 760674577 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-36081 | Film No.: 21925208
SIC: 2834 Pharmaceutical Preparations